Union Bancaire Privee, Ubp Sa Bristol Myers Squibb CO Transaction History
Union Bancaire Privee, Ubp Sa
- $6.72 Billion
- Q4 2025
A detailed history of Union Bancaire Privee, Ubp Sa transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Union Bancaire Privee, Ubp Sa holds 506,020 shares of BMY stock, worth $23.7 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
506,020
Previous 14,144
3477.63%
Holding current value
$23.7 Million
Previous $637,000
3618.37%
% of portfolio
0.35%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding BMY
# of Institutions
2,735Shares Held
1.58BCall Options Held
28.7MPut Options Held
28.6M-
Vanguard Group Inc Valley Forge, PA199MShares$9.3 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...